Exocrine Pancreatic Insufficiency Clinical Trials

5 recruiting

Exocrine Pancreatic Insufficiency Trials at a Glance

8 actively recruiting trials for exocrine pancreatic insufficiency are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 4 with 3 trials, with the heaviest enrollment activity in Pittsburgh, Baltimore, and Boston. Lead sponsors running exocrine pancreatic insufficiency studies include INC Research Australia Pty Ltd, Inova Health Care Services, and Anna Evans Phillips.

Browse exocrine pancreatic insufficiency trials by phase

About Exocrine Pancreatic Insufficiency Clinical Trials

Looking for clinical trials for Exocrine Pancreatic Insufficiency? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Exocrine Pancreatic Insufficiency trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Exocrine Pancreatic Insufficiency clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 4

A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

Chronic PancreatitisExocrine Pancreatic Insufficiency
Mayo Clinic24 enrolled1 locationNCT07285863
Recruiting
Phase 4

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

Chronic PancreatitisExocrine Pancreatic InsufficiencyRecurrent Acute Pancreatitis
Anna Evans Phillips80 enrolled2 locationsNCT07418593
Recruiting

Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM)Exocrine Pancreatic Insufficiency (EPI)Pancreatogenic Diabetes Mellitus
West Kazakhstan Marat Ospanov Medical University310 enrolled1 locationNCT07512934
Recruiting
Not Applicable

Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure

Exocrine Pancreatic InsufficiencyMulti Organ Failure
Inova Health Care Services32 enrolled1 locationNCT05710315
Recruiting
Phase 4

Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency

Exocrine Pancreatic Insufficiency
Ohio State University60 enrolled5 locationsNCT06477159
Recruiting

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

Myelodysplastic SyndromesShwachman-Diamond SyndromeSDS+24 more
Shwachman-Diamond Syndrome Alliance Inc8,000 enrolled1 locationNCT06999954
Recruiting
Phase 3

Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

PancreatitisExocrine Pancreatic Insufficiency (EPI)
Massachusetts General Hospital60 enrolled1 locationNCT06691893
Recruiting

MS1819-SD phase IIa clinical trial for patients with exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis (CP) and/or distal pancreatectomy.

Exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis (CP)Exocrine pancreatic insufficiency (EPI) caused by distal pancreatectomy.
INC Research Australia Pty Ltd13 enrolled6 locationsACTRN12616000962437